BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29199261)

  • 1. TBX19 is overexpressed in colorectal cancer and associated with lymph node metastasis.
    Ando J; Saito M; Imai JI; Ito E; Yanagisawa Y; Honma R; Saito K; Tachibana K; Momma T; Ohki S; Ohtake T; Watanabe S; Waguri S; Kono K; Takenoshita S
    Fukushima J Med Sci; 2017 Dec; 63(3):141-151. PubMed ID: 29199261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.
    Ji X; Chen X; Zhang B; Xie M; Zhang T; Luo X; Liu D; Feng Y; Wang Y; Sun M; Li C; Huang W; Xia L
    Oncogene; 2022 Apr; 41(15):2225-2238. PubMed ID: 35217793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of FIH-1 and SOCS3 expression in KRAS mutant and wild-type patients with colorectal cancer.
    Vakil L; Najafipour R; Rakhshani N; Zamani F; Morakabati A; Javadi A
    Tumour Biol; 2016 Jul; 37(7):8841-8. PubMed ID: 26749281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
    Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
    Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.
    Imaoka H; Toiyama Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Carcinogenesis; 2015 Mar; 36(3):346-54. PubMed ID: 25568185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42.
    Wang YX; Chen YR; Liu SS; Ye YP; Jiao HL; Wang SY; Xiao ZY; Wei WT; Qiu JF; Liang L; Liao WT; Ding YQ
    Oncotarget; 2016 Dec; 7(51):84826-84838. PubMed ID: 27769041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma].
    Cao YC; Yang F; Liu XH; Xin X; Wang CC; Geng M
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):674-8. PubMed ID: 23159080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
    Shen X; Bai Y; Luo B; Zhou X
    Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association Between HSP90/topoisomerase I Immunophenotype and the Clinical Features of Colorectal Cancers in Respect to
    Bar JK; Lis-Nawara A; Grelewski P; Noga L; Grzebieniak Z; Jeleń M
    Anticancer Res; 2017 Sep; 37(9):4953-4960. PubMed ID: 28870917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.
    Li W; Qiu T; Zhi W; Shi S; Zou S; Ling Y; Shan L; Ying J; Lu N
    BMC Cancer; 2015 May; 15():340. PubMed ID: 25929517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of GAB2, a scaffolding/docking protein acting downstream of EGFR in human colorectal cancer.
    Matsumura T; Sugimachi K; Takahashi Y; Uchi R; Sawada G; Ueda M; Hirata H; Sakimura S; Ueo H; Takano Y; Kurashige J; Shinden Y; Eguchi H; Sudo T; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S743-9. PubMed ID: 25029990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations Between Loss of ARID1A Expression and Clinicopathologic and Genetic Variables in T1 Early Colorectal Cancer.
    Kishida Y; Oishi T; Sugino T; Shiomi A; Urakami K; Kusuhara M; Yamaguchi K; Kitagawa Y; Ono H
    Am J Clin Pathol; 2019 Sep; 152(4):463-470. PubMed ID: 31263894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
    Alqurashi N; Gopalan V; Smith RA; Lam AK
    Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases.
    Maurer CA; Graber HU; Friess H; Beyermann B; Willi D; Netzer P; Zimmermann A; Büchler MW
    Surgery; 1999 Nov; 126(5):869-80. PubMed ID: 10568187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.
    Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J
    PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.